Global and United States Genitourinary Drugs Market Size, Status and Forecast 2020-2026

Global and United States Genitourinary Drugs Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genitourinary Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Urologicals
1.2.3 Hormonal Therapy
1.2.4 Gynecological
1.2.5 Anti-infectives
1.3 Market by Application
1.3.1 Global Genitourinary Drugs Market Share by Application: 2020 VS 2026
1.3.2 Prostate Cancer
1.3.3 Ovarian Cancer
1.3.4 Bladder Cancer
1.3.5 Cervical Cancer
1.3.6 Renal Cancer
1.3.7 Erectile Dysfunction
1.3.8 Urinary Tract Infections
1.3.9 Urinary Incontinence & Overactive Bladder
1.3.10 Sexually Transmitted Diseases
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Genitourinary Drugs Market Perspective (2015-2026)
2.2 Global Genitourinary Drugs Growth Trends by Regions
2.2.1 Genitourinary Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Genitourinary Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Genitourinary Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genitourinary Drugs Players by Market Size
3.1.1 Global Top Genitourinary Drugs Players by Revenue (2015-2020)
3.1.2 Global Genitourinary Drugs Revenue Market Share by Players (2015-2020)
3.2 Global Genitourinary Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Genitourinary Drugs Revenue
3.4 Global Genitourinary Drugs Market Concentration Ratio
3.4.1 Global Genitourinary Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genitourinary Drugs Revenue in 2019
3.5 Key Players Genitourinary Drugs Area Served
3.6 Key Players Genitourinary Drugs Product Solution and Service
3.7 Date of Enter into Genitourinary Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genitourinary Drugs Breakdown Data by Type (2015-2026)
4.1 Global Genitourinary Drugs Historic Market Size by Type (2015-2020)
4.2 Global Genitourinary Drugs Forecasted Market Size by Type (2021-2026)
5 Genitourinary Drugs Breakdown Data by Application (2015-2026)
5.1 Global Genitourinary Drugs Historic Market Size by Application (2015-2020)
5.2 Global Genitourinary Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Genitourinary Drugs Market Size (2015-2026)
6.2 North America Genitourinary Drugs Market Size by Type (2015-2020)
6.3 North America Genitourinary Drugs Market Size by Application (2015-2020)
6.4 North America Genitourinary Drugs Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Genitourinary Drugs Market Size (2015-2026)
7.2 Europe Genitourinary Drugs Market Size by Type (2015-2020)
7.3 Europe Genitourinary Drugs Market Size by Application (2015-2020)
7.4 Europe Genitourinary Drugs Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Genitourinary Drugs Market Size (2015-2026)
8.2 China Genitourinary Drugs Market Size by Type (2015-2020)
8.3 China Genitourinary Drugs Market Size by Application (2015-2020)
8.4 China Genitourinary Drugs Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Genitourinary Drugs Market Size (2015-2026)
9.2 Japan Genitourinary Drugs Market Size by Type (2015-2020)
9.3 Japan Genitourinary Drugs Market Size by Application (2015-2020)
9.4 Japan Genitourinary Drugs Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Genitourinary Drugs Market Size (2015-2026)
10.2 Southeast Asia Genitourinary Drugs Market Size by Type (2015-2020)
10.3 Southeast Asia Genitourinary Drugs Market Size by Application (2015-2020)
10.4 Southeast Asia Genitourinary Drugs Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Genitourinary Drugs Introduction
11.1.4 Novartis AG Revenue in Genitourinary Drugs Business (2015-2020))
11.1.5 Novartis AG Recent Development
11.2 Genentech
11.2.1 Genentech Company Details
11.2.2 Genentech Business Overview
11.2.3 Genentech Genitourinary Drugs Introduction
11.2.4 Genentech Revenue in Genitourinary Drugs Business (2015-2020)
11.2.5 Genentech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Genitourinary Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Urologicals
Table 4. Key Players of Hormonal Therapy
Table 5. Key Players of Gynecological
Table 6. Key Players of Anti-infectives
Table 7. Global Genitourinary Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Genitourinary Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Genitourinary Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Genitourinary Drugs Market Share by Regions (2015-2020)
Table 11. Global Genitourinary Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Genitourinary Drugs Market Share by Regions (2021-2026)
Table 13. Genitourinary Drugs Market Market Trends
Table 14. Genitourinary Drugs Market Drivers
Table 15. Genitourinary Drugs Market Challenges
Table 16. Genitourinary Drugs Market Restraints
Table 17. Global Genitourinary Drugs Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Genitourinary Drugs Market Share by Players (2015-2020)
Table 19. Global Top Genitourinary Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genitourinary Drugs as of 2019)
Table 20. Global Genitourinary Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Genitourinary Drugs Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Genitourinary Drugs Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Genitourinary Drugs Market Size Share by Type (2015-2020)
Table 26. Global Genitourinary Drugs Revenue Market Share by Type (2021-2026)
Table 27. Global Genitourinary Drugs Market Size Share by Application (2015-2020)
Table 28. Global Genitourinary Drugs Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Genitourinary Drugs Market Size Share by Application (2021-2026)
Table 30. North America Genitourinary Drugs Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Genitourinary Drugs Market Share by Type (2015-2020)
Table 32. North America Genitourinary Drugs Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Genitourinary Drugs Market Share by Application (2015-2020)
Table 34. North America Genitourinary Drugs Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Genitourinary Drugs Market Share by Country (2015-2020)
Table 36. Europe Genitourinary Drugs Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Genitourinary Drugs Market Share by Type (2015-2020)
Table 38. Europe Genitourinary Drugs Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Genitourinary Drugs Market Share by Application (2015-2020)
Table 40. Europe Genitourinary Drugs Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Genitourinary Drugs Market Share by Country (2015-2020)
Table 42. China Genitourinary Drugs Market Size by Type (2015-2020) (US$ Million)
Table 43. China Genitourinary Drugs Market Share by Type (2015-2020)
Table 44. China Genitourinary Drugs Market Size by Application (2015-2020) (US$ Million)
Table 45. China Genitourinary Drugs Market Share by Application (2015-2020)
Table 46. China Genitourinary Drugs Market Size by Region (US$ Million) (2015-2020)
Table 47. China Genitourinary Drugs Market Share by Region (2015-2020)
Table 48. Japan Genitourinary Drugs Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Genitourinary Drugs Market Share by Type (2015-2020)
Table 50. Japan Genitourinary Drugs Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Genitourinary Drugs Market Share by Application (2015-2020)
Table 52. Japan Genitourinary Drugs Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Genitourinary Drugs Market Share by Country (2015-2020)
Table 54. Southeast Asia Genitourinary Drugs Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Genitourinary Drugs Market Share by Type (2015-2020)
Table 56. Southeast Asia Genitourinary Drugs Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Genitourinary Drugs Market Share by Application (2015-2020)
Table 58. Southeast Asia Genitourinary Drugs Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Genitourinary Drugs Market Share by Country (2015-2020)
Table 60. Novartis AG Company Details
Table 61. Novartis AG Business Overview
Table 62. Novartis AG Product
Table 63. Novartis AG Revenue in Genitourinary Drugs Business (2015-2020) (US$ Million)
Table 64. Novartis AG Recent Development
Table 65. Genentech Company Details
Table 66. Genentech Business Overview
Table 67. Genentech Product
Table 68. Genentech Revenue in Genitourinary Drugs Business (2015-2020) (US$ Million)
Table 69. Genentech Recent Development
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genitourinary Drugs Market Share by Type: 2020 VS 2026
Figure 2. Urologicals Features
Figure 3. Hormonal Therapy Features
Figure 4. Gynecological Features
Figure 5. Anti-infectives Features
Figure 6. Global Genitourinary Drugs Market Share by Application: 2020 VS 2026
Figure 7. Prostate Cancer Case Studies
Figure 8. Ovarian Cancer Case Studies
Figure 9. Bladder Cancer Case Studies
Figure 10. Cervical Cancer Case Studies
Figure 11. Renal Cancer Case Studies
Figure 12. Erectile Dysfunction Case Studies
Figure 13. Urinary Tract Infections Case Studies
Figure 14. Urinary Incontinence & Overactive Bladder Case Studies
Figure 15. Sexually Transmitted Diseases Case Studies
Figure 16. Genitourinary Drugs Report Years Considered
Figure 17. Global Genitourinary Drugs Market Size (US$ Million), YoY Growth 2015-2026
Figure 18. Global Genitourinary Drugs Market Share by Regions: 2020 VS 2026
Figure 19. Global Genitourinary Drugs Market Share by Regions (2021-2026)
Figure 20. Global Genitourinary Drugs Market Share by Players in 2019
Figure 21. Global Top Genitourinary Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genitourinary Drugs as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Genitourinary Drugs Revenue in 2019
Figure 23. North America Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. United States Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Canada Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Europe Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Germany Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. France Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. U.K. Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Italy Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Russia Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Nordic Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Europe Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Asia-Pacific Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. China Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Japan Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. South Korea Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Southeast Asia Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. India Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Australia Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Asia-Pacific Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Latin America Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Mexico Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Brazil Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Middle East & Africa Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Turkey Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Saudi Arabia Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. UAE Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 49. Rest of Middle East & Africa Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 50. Novartis AG Revenue Growth Rate in Genitourinary Drugs Business (2015-2020)
Figure 51. Genentech Revenue Growth Rate in Genitourinary Drugs Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Overactive Bladder Treatment Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Overactive Bladder Treatment market size was valued at US$ 4989.1 million in 2023. With growing demand in downstream market, the Overactive Bladder Treatment is forecast to a readjusted size of US$ 6182.8 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Overactive Bladder Treatment market. Overactive Bladder Treatment are expected to show stable growth......

Global Genitourinary Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 110

Market Overview of Global Genitourinary Drugs market: According to our latest research, the global Genitourinary Drugs market looks promising in the next 5 years. As of 2022, the global Genitourinary Drugs market was estimated at USD 30442.38 million, and it's anticipated to reach USD 32574.96 million in 2028, with a CAGR of 1.13% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......

Global Urinary Tract Infection Treatment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Urinary Tract Infection Treatment market: According to our latest research, the global Urinary Tract Infection Treatment market looks promising in the next 5 years. As of 2022, the global Urinary Tract Infection Treatment market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. A urinary tract infection is an infection that can occur in any area of the urinary tract, i......

Global Overactive Bladder Treatment Market Research Report 2023, Forecast to 2028

Published: 02-Nov-2023        Price: US 2680 Onwards        Pages: 130

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Global Overactive Bladder Treatment Professional Survey Report 2023, Forecast to 2028

Published: 02-Nov-2023        Price: US 3280 Onwards        Pages: 103

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Global Overactive Bladder Treatment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 17-Oct-2023        Price: US 3380 Onwards        Pages: 105

Market Overview of Global Overactive Bladder Treatment market: According to our latest research, the global Overactive Bladder Treatment market looks promising in the next 5 years. As of 2022, the global Overactive Bladder Treatment market was estimated at USD 3983.87 million, and it's anticipated to reach USD 5304.63 million in 2028, with a CAGR of 4.89% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......

Genitourinary Collaboration and Licensing Deals 2016-2023

Published: 01-Oct-2023        Price: US 3995 Onwards        Pages: 150

Genitourinary Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the genitourinary deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of genitourinary deals from 2016 to 2023. The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms. Underst......

Global Genitourinary Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 70

The global Genitourinary Drugs market is projected to grow from US$ 29570 million in 2023 to US$ 35930 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.3% during the forecast period. The US & Canada market for Genitourinary Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Genitourinary Drugs is estimated to increase from $ million in 202......

Global Overactive Bladder Therapeutics Market Insights, Forecast to 2029

Published: 28-Jun-2023        Price: US 4900 Onwards        Pages: 88

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device. Market Analysis and Insights: Global Overactive Bladder Therapeutics Market The global Overactive Bladder Therapeutics market is projected to grow from US$ 5240.8 million in 2023 t......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs